English

Eligibility Breast Cancer NCT00811135

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >=18 years of age;
Description

Adult | Age

Data type

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
breast cancer with measurable locally recurrent or metastatic lesions;
Description

Breast Carcinoma | Measurable lesion recurrent locally | Measurable lesion metastatic

Data type

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C2945760
UMLS CUI [2,3]
C1517927
UMLS CUI [3,1]
C1513041
UMLS CUI [3,2]
C1522484
candidate for chemotherapy;
Description

Indication Chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0392920
her2-positive disease;
Description

Disease HER2/Neu Positive

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2348909
ecog ps of <=2.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous anticancer therapy for metastatic breast cancer;
Description

Cancer treatment Secondary malignant neoplasm of female breast

Data type

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0346993
previous radiotherapy for metastatic breast cancer (except for adjuvant radiotherapy >=6 months before enrollment);
Description

Therapeutic radiology procedure Secondary malignant neoplasm of female breast | Exception Adjuvant Radiotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0346993
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0242939
chronic daily treatment with corticosteroids (>=10mg/day), aspirin (>325 mg/day) or clopidogrel (>75mg/day);
Description

Adrenal Cortex Hormones U/day | Aspirin U/day | Clopidogrel U/day

Data type

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0456683
UMLS CUI [2,1]
C0004057
UMLS CUI [2,2]
C0456683
UMLS CUI [3,1]
C0070166
UMLS CUI [3,2]
C0456683
other primary tumor within last 5 years, except for adequately treated cervical cancer in situ, squamous or basal cell skin cancer;
Description

Primary tumor | Exception Carcinoma in situ of uterine cervix Treated | Exception Squamous cell carcinoma of skin Treated | Exception Basal cell carcinoma Treated

Data type

boolean

Alias
UMLS CUI [1]
C0677930
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0851140
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0007117
UMLS CUI [4,3]
C1522326
uncontrolled hypertension or significant cardiovascular disease.
Description

Uncontrolled hypertension | Cardiovascular Diseases

Data type

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0007222
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT00811135

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, >=18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Breast Carcinoma | Measurable lesion recurrent locally | Measurable lesion metastatic
Item
breast cancer with measurable locally recurrent or metastatic lesions;
boolean
C0678222 (UMLS CUI [1])
C1513041 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C1513041 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
Indication Chemotherapy
Item
candidate for chemotherapy;
boolean
C3146298 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Disease HER2/Neu Positive
Item
her2-positive disease;
boolean
C0012634 (UMLS CUI [1,1])
C2348909 (UMLS CUI [1,2])
ECOG performance status
Item
ecog ps of <=2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cancer treatment Secondary malignant neoplasm of female breast
Item
previous anticancer therapy for metastatic breast cancer;
boolean
C0920425 (UMLS CUI [1,1])
C0346993 (UMLS CUI [1,2])
Therapeutic radiology procedure Secondary malignant neoplasm of female breast | Exception Adjuvant Radiotherapy
Item
previous radiotherapy for metastatic breast cancer (except for adjuvant radiotherapy >=6 months before enrollment);
boolean
C1522449 (UMLS CUI [1,1])
C0346993 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0242939 (UMLS CUI [2,2])
Adrenal Cortex Hormones U/day | Aspirin U/day | Clopidogrel U/day
Item
chronic daily treatment with corticosteroids (>=10mg/day), aspirin (>325 mg/day) or clopidogrel (>75mg/day);
boolean
C0001617 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0070166 (UMLS CUI [3,1])
C0456683 (UMLS CUI [3,2])
Primary tumor | Exception Carcinoma in situ of uterine cervix Treated | Exception Squamous cell carcinoma of skin Treated | Exception Basal cell carcinoma Treated
Item
other primary tumor within last 5 years, except for adequately treated cervical cancer in situ, squamous or basal cell skin cancer;
boolean
C0677930 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0851140 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
Uncontrolled hypertension | Cardiovascular Diseases
Item
uncontrolled hypertension or significant cardiovascular disease.
boolean
C1868885 (UMLS CUI [1])
C0007222 (UMLS CUI [2])
Back to the top of the page